Objectives: To estimate stage-specific transition probabilities in individuals coinfected with
HIV and hepatitis C virus (HCV), to examine the effect of covariates on these rates, and to …

Abreviaturas usadas en este Trabajo: IC: intervalo de confianza; RVT: respuesta virológica
temprana; TAAA: terapia antirretroviral altamente activa; IHA: índice histiológico activo; VIH …

These are the first World Health Organization (WHO) guidelines for the prevention care and
treatment of persons living with CHB infection and complement similar recent published …

It is important to realize that guidelines cannot always account for individual variation among
patients. They are not intended to supplant physician judgment with respect to particular …

ISBN 978 92 4 459976 1(NLM classification: WC 503.2)© всемирная организация
здравоохранения, 2010 г. все права защищены. публикации всемирной организации …

The article presents guidelines from the British HIV Association for the treatment of HIV-1-
infected adults using antiretroviral therapy. It presents data from clinical trials on the …

Background: Chronic hepatitis C in HIV-infected patients is an increasing cause of death
dependent on the development of liver fibrosis, which is currently assessed by liver biopsy …

BACKGROUND/AIMS: HIV/HCV-coinfected patients reportedly have a faster fibrosis
progression rate (FPR) than HCV-monoinfected patients. This study examined whether HIV …

Background. It is unclear whether coinfection with hepatitis C virus (HCV) increases mortality
in patients with human immunodeficiency virus (HIV) infection during the era of highly active …

The impact of human immunodeficiency virus (HIV) coinfection on the survival of patients
with hepatitis C virus (HCV)‐related end‐stage liver disease (ESLD) is unknown. Because …